Determining resuscitation outcomes in combat casualties: Design of the Deployed Hemostatic Emergency Resuscitation of Traumatic Exsanguinating Shock (Deployed HEROES) study

Jennifer M. Gurney, Amanda M. Staudt, Deborah J. Del Junco, John Holcomb, Matthew Martin, Phil Spinella, Jennifer D. Trevino, Jason B. Corley, Audra L. Taylor, Andrew Rohrer, Martin Schreiber, Andrew Cap

Research output: Contribution to journalArticlepeer-review

Abstract

BACKGROUND During the course of the recent conflicts, the recommendations for resuscitation practices have evolved, but there has been no comprehensive comparative effectiveness study of these resuscitation strategies. The objective of this study was to describe the development and study design of the Deployed Hemostatic Emergency Resuscitation of Traumatic Exsanguinating Shock (Deployed HEROES) study - the first comprehensive analysis of military resuscitation practices in the deployed environment from October 2001 to October 2019. METHODS This retrospective cohort study uses the Department of Defense Trauma Registry, Armed Services Blood Program database, and Military Trauma Mortality Review, while abstractors will use Theater Medical Data Store and Web Interface Patient Records to collect transfusion timing data. This study includes patients, who received blood products or died before receiving blood, treated at US military medical treatment facilities. The primary endpoints are survival at 6 hours, 24 hours, and 30 days postinjury. Secondary outcomes include infection, renal dysfunction, pulmonary dysfunction, and thromboembolic event. Exposure will be defined by blood product transfusion. Study groups will be frequency matched. Cox proportional hazards will compare patients who received warm fresh whole blood, low titer type-O whole blood, or only component therapy, while using adjustment for type of blood product transfused as a time-dependent covariate. Multilevel mixed-effects logistic regression will determine the effect of incompatible plasma in low titer type-O whole blood. RESULTS An analysis plan for the Deployed HEROES study was developed with the aim of minimizing bias. CONCLUSION This study will inform the optimal resuscitation strategies, which will potentially have a substantial impact on combat mortality. If whole blood is found to be the optimal transfusion strategy, this finding will be crucial in future operating environments involving dispersed medical assets. These results will provide critical information necessary for combat casualty care guidelines. LEVEL OF EVIDENCE Prognostic and epidemiological; Level III.

Original languageEnglish (US)
Pages (from-to)S22-S29
JournalJournal of Trauma and Acute Care Surgery
Volume93
Issue number2
DOIs
StatePublished - Aug 1 2022
Externally publishedYes

Keywords

  • LTOWB
  • Whole blood
  • combat casualty care
  • resuscitation
  • transfusion outcomes

ASJC Scopus subject areas

  • Surgery
  • Critical Care and Intensive Care Medicine

Fingerprint

Dive into the research topics of 'Determining resuscitation outcomes in combat casualties: Design of the Deployed Hemostatic Emergency Resuscitation of Traumatic Exsanguinating Shock (Deployed HEROES) study'. Together they form a unique fingerprint.

Cite this